Translational Development Acquisition Corp.

Translational Development Acquisition Corp.

TDAC·NASDAQ

$10.74

-0.19%
Financial ServicesShell Companies

Translational Development Acquisition Corp. does not have significant operations. It intends to effect a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. Translational Development Acquisition Corp. was incorporated in 2022 and is based in New York, New York.

At a Glance

Live Snapshot
Market Cap$235.29M
EPS0.3700
P/E Ratio29.03
Earnings Date05/15/2026
tdac

Translational Development Acquisition Corp. Street Expectations Map

TDAC · NASDAQ

No Target Data

No analyst price targets available for tdac.

tdac

Translational Development Acquisition Corp. Forward Estimates of Revenue

TDAC · NASDAQ
Latest Revenue
0.00
FY 2025
Avg Estimate
N/A
FY N/A
Estimate Range
N/A - N/A
Analyst Spread

Forward Growth Analysis

OutlookCautious

Analyst skepticism evident—carefully evaluate risks before investment decisions.

tdac

Translational Development Acquisition Corp. Forward Estimates of Net Income

TDAC · NASDAQ
Latest Net Income
6.36M
FY 2025
Avg Estimate
N/A
FY N/A
Estimate Range
N/A - N/A
Analyst Spread

Forward Growth Analysis

OutlookCautious

Analyst skepticism evident—carefully evaluate risks before investment decisions.

tdac

Translational Development Acquisition Corp. Forward Estimates of EPS

TDAC · NASDAQ
Latest EPS
0.37
FY 2025
Avg Estimate
N/A
FY N/A
Estimate Range
N/A - N/A
Analyst Spread

Forward Growth Analysis

OutlookCautious

Analyst skepticism evident—carefully evaluate risks before investment decisions.

tdac

Translational Development Acquisition Corp. Forward Estimates of EBIT

TDAC · NASDAQ
Latest EBIT
-944.54K
FY 2025
Avg Estimate
N/A
FY N/A
Estimate Range
N/A - N/A
Analyst Spread

Forward Growth Analysis

OutlookCautious

Analyst skepticism evident—carefully evaluate risks before investment decisions.

tdac

Translational Development Acquisition Corp. Forward Estimates of EBITDA

TDAC · NASDAQ
Latest EBITDA
-944.54K
FY 2025
Avg Estimate
N/A
FY N/A
Estimate Range
N/A - N/A
Analyst Spread

Forward Growth Analysis

OutlookCautious

Analyst skepticism evident—carefully evaluate risks before investment decisions.

tdac

Translational Development Acquisition Corp. Forward Estimates of SG&A Expense

TDAC · NASDAQ
Latest SG&A Expense
944.54K
FY 2025
Avg Estimate
N/A
FY N/A
Estimate Range
N/A - N/A
Analyst Spread

Forward Growth Analysis

OutlookCautious

Analyst skepticism evident—carefully evaluate risks before investment decisions.

tdac

Translational Development Acquisition Corp. Insider Positioning

TDAC · NASDAQ

During the last 12 months, insiders have purchased $614K worth of TDAC shares, with no selling activity reported.

3 Months

Bought

53.4K

614.04K

Sold

0

0.00

Net Activity

+614K

+$614K

3-6 Months

Bought

0

0.00

Sold

0

0.00

Net Activity

+0

+$0

6-9 Months

Bought

0

0.00

Sold

0

0.00

Net Activity

+0

+$0

9-12 Months

Bought

0

0.00

Sold

0

0.00

Net Activity

+0

+$0

Top Buyers

1
HMB

Hoffman Michael B

Director, Officer: Chairman And Ceo

53.4K shares1 transactions

$614K

Top Sellers

No selling activity

Insider Activity Analysis

Net Insider Sentiment

Bullish

Strong bullish signal with $614K net buying. Insiders are aggressively accumulating shares, suggesting significant confidence in future prospects.

Buy/Sell Ratio

∞:1

Perfect buy/sell ratio. Only buying activity with zero selling—the most bullish possible insider signal.

Recent Trend (3 Months)

$614K

Very strong recent buying momentum. Recent insider purchases significantly outpace sales, suggesting near-term optimism.

Insider Participation

High Buying

1 insider buyers vs. 0 sellers. Broad-based buying across management team suggests widespread confidence.

Insider Activity Insight

Unanimous insider buying: Zero selling combined with active buying is rare and typically very bullish. Insiders appear to see significant upside with limited downside risk.